NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
Advertisement
NewsRx | Free Trials
Advertisement
----------
------------
NewsRx on Facebook
-----
Press Release Submissions
PR Login
*
*

Pain & Central Nervous System Week

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Pain & Central Nervous System Week

Learn More

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now



Life Sciences



Research conducted at Federico II University, Department of Neurological Sciences has provided new information about life sciences



June 1st, 2009

Data detailed in 'Course and outcome of a voltage-gated potassium channel antibody negative Morvan's syndrome' have been presented. According to recent research published in the journal Neurological Sciences, "Morvan's syndrome is a rare disease characterized by peripheral nerve hyperexcitability, associated with CNS and autonomic systems involvement. High serum voltage-gated potassium channel (VGKC) antibody titers have been reported, and, till now, Morvan's syndrome has been considered as a VGKC antibody associated disease."

"We describe a patient with Morvan's syndrome associated with myasthenia gravis and a thymoma in his previous history, with surprisingly...


Source: Pain & Central Nervous System Week (2009-06-01)

NewsRx Passes
Advertisement
More Articles

Related Topics

------------------------
Security by Verisign PR Login